Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Sep 24, 2024
10-Q Aug 14, 2024 10-Q
8-K Aug 14, 2024 8-K
S-8 Jul 1, 2024 FORM S-8
8-K Jun 28, 2024 8-K
ARS May 17, 2024 ARS
DEFA14A May 17, 2024 DEFA14A
10-Q May 10, 2024 10-Q
8-K May 10, 2024 8-K
DEF 14A Apr 29, 2024 DEF 14A
4 Apr 3, 2024
10-K Mar 14, 2024 10-K
8-K Mar 14, 2024 8-K
SC 13G/A Jan 2, 2024 SC 13G/A
8-K Dec 26, 2023 8-K
10-Q Nov 6, 2023 10-Q
8-K Nov 6, 2023 8-K
4 Oct 20, 2023
4 Oct 3, 2023
4 Oct 3, 2023
4 Oct 3, 2023
4 Oct 3, 2023
4 Oct 3, 2023
4 Sep 15, 2023 OWNERSHIP DOCUMENT
3 Sep 15, 2023 OWNERSHIP DOCUMENT
← Newer Page 4 of 38 · 935 filings Older →